AgResearch
Browse
Clin_Translat Immunol 6(1)_e125 - Lvan den Elsen et al 200117.pdf (1.25 MB)

Embracing the gut microbiota: the new frontier for inflammatory and infectious diseases

Download (1.25 MB)
journal contribution
posted on 2023-05-03, 13:23 authored by Lieke van den Elsen, Hazel Poyntz, Laura Weyrich, Wayne Young, Elizabeth Forbes-Blom
The gut microbiota provides essential signals for the development and appropriate function of the immune system. Through this critical contribution to immune fitness, the gut microbiota plays a key role in health and disease. Recent advances in the technological applications to study microbial communities and their functions have contributed to a rapid increase in host-microbiota research. Although it still remains difficult to define a so-called “normal” or “healthy” microbial composition, alterations in the gut microbiota have been shown to influence the susceptibility of the host to different diseases. Current translational research combined with recent technological and computational advances have enabled in-depth study of the link between microbial composition and immune function, addressing the interplay between the gut microbiota and immune responses. As such, beneficial modulation of the gut microbiota is a promising clinical target for many prevalent diseases including inflammatory bowel disease, metabolic abnormalities such as obesity, reduced insulin sensitivity and low-grade inflammation, allergy and protective immunity against infections.

History

Rights statement

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Language

  • English

Does this contain Māori information or data?

  • No

Publisher

Springer Nature

Journal title

Clinical & Translational Immunology

ISSN

2050-0068

Citation

van den Elsen, L. W. J., Poyntz, H. C., Weyrich, L. S., Young, W., & Forbes-Blom, E. E. (2017). Embracing the gut microbiota: the new frontier for inflammatory and infectious diseases. Clinical & Translational Immunology, 6(1), e125. doi:10.1038/cti.2016.91

Funder

Malaghan Institue of Medical Research

Contract number

A22669

Job code

11885

Usage metrics

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC